These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 31394201

  • 1. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls.
    Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, de Andrade MF, Molina CAF, Tucci S, Hirsch E, Tanus-Santos JE, Lacchini R.
    Nitric Oxide; 2019 Nov 01; 92():11-17. PubMed ID: 31394201
    [Abstract] [Full Text] [Related]

  • 2. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy.
    Azevedo AMM, Brites-Anselmi G, Pinheiro LC, de Almeida Belo V, Coeli-Lacchini FB, Molina CAF, de Andrade MF, Tucci S, Hirsch E, Tanus-Santos JE, Lacchini R.
    Nitric Oxide; 2017 Dec 01; 71():44-51. PubMed ID: 29074293
    [Abstract] [Full Text] [Related]

  • 3. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 01; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 4. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
    Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE.
    PLoS One; 2010 Mar 01; 5(3):e9462. PubMed ID: 20209122
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R.
    Nephrol Dial Transplant; 2013 Apr 01; 28(4):964-71. PubMed ID: 23129820
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C, Mowat F, Sayed H, Mehad M, Duluc L, Piper S, Luhmann U, Nandi M, Kelly P, Smith A, Ali R, Leiper J, Bainbridge J.
    Exp Eye Res; 2016 Jun 01; 147():148-155. PubMed ID: 27181226
    [Abstract] [Full Text] [Related]

  • 9. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Jun 01; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 10. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
    Amir M, Hassanein SI, Abdel Rahman MF, Gad MZ.
    Mol Biol Rep; 2018 Dec 01; 45(6):2411-2419. PubMed ID: 30284143
    [Abstract] [Full Text] [Related]

  • 11. Early and late-onset preeclampsia: effects of DDAH2 polymorphisms on ADMA levels and association with DDAH2 haplotypes.
    Mendes FS, Luizon MR, Lopes ACDS, Pereira DA, Evangelista FCG, Godoi LC, Dusse LM, Alpoim PN.
    Rev Bras Ginecol Obstet; 2024 Dec 01; 46():. PubMed ID: 38765527
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia causes increased monocyte nitric oxide synthesis which is mediated by changes in dimethylarginine dimethylaminohydrolase 2 expression in animal and human models of normobaric hypoxia.
    Lambden S, Martin D, Vanezis K, Lee B, Tomlinson J, Piper S, Boruc O, Mythen M, Leiper J.
    Nitric Oxide; 2016 Aug 31; 58():59-66. PubMed ID: 27319282
    [Abstract] [Full Text] [Related]

  • 13. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X, Zhang P, Kwak D, Fassett J, Yue W, Atzler D, Hu X, Liu X, Wang H, Lu Z, Guo H, Schwedhelm E, Böger RH, Chen P, Chen Y.
    Basic Res Cardiol; 2017 Aug 17; 112(5):55. PubMed ID: 28819685
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice.
    Hannemann J, Glatzel A, Hillig J, Zummack J, Schumacher U, Lüneburg N, Harbaum L, Böger R.
    Front Physiol; 2020 Aug 17; 11():597559. PubMed ID: 33281630
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.
    Aktoz T, Aktoz M, Tatlı E, Kaplan M, Turan FN, Barutcu A, Atakan IH, Demir M, Altun A.
    Int Urol Nephrol; 2010 Dec 17; 42(4):873-9. PubMed ID: 20091222
    [Abstract] [Full Text] [Related]

  • 16. miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia.
    Iannone L, Zhao L, Dubois O, Duluc L, Rhodes CJ, Wharton J, Wilkins MR, Leiper J, Wojciak-Stothard B.
    Biochem J; 2014 Aug 15; 462(1):103-12. PubMed ID: 24895913
    [Abstract] [Full Text] [Related]

  • 17. A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.
    Ding H, Wu B, Wang H, Lu Z, Yan J, Wang X, Shaffer JR, Hui R, Wang DW.
    Circ Res; 2010 Apr 02; 106(6):1145-52. PubMed ID: 20167924
    [Abstract] [Full Text] [Related]

  • 18. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
    Paroni R, Barassi A, Ciociola F, Dozio E, Finati E, Fermo I, Ghilardi F, Colpi GM, Corsi MM, Melzi d'Eril GV.
    Int J Androl; 2012 Oct 02; 35(5):660-7. PubMed ID: 22519580
    [Abstract] [Full Text] [Related]

  • 19. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
    Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H.
    Circ Res; 2007 Jul 20; 101(2):e2-10. PubMed ID: 17601800
    [Abstract] [Full Text] [Related]

  • 20. Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods.
    Kozlova AA, Vaganova AN, Rodionov RN, Gainetdinov RR, Bernhardt N.
    Int J Mol Sci; 2022 Oct 07; 23(19):. PubMed ID: 36233204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.